ID: ALA4471565

Max Phase: Preclinical

Molecular Formula: C28H28F2N2O7

Molecular Weight: 542.54

Molecule Type: Unknown

Representations

Canonical SMILES:  C=C1C(=O)O[C@H]2[C@H]1CC/C(COC(=O)Cn1cc(F)c(=O)n(Cc3ccccc3F)c1=O)=C\CC[C@@]1(C)O[C@@H]21

Standard InChI:  InChI=1S/C28H28F2N2O7/c1-16-19-10-9-17(6-5-11-28(2)24(39-28)23(19)38-26(16)35)15-37-22(33)14-31-13-21(30)25(34)32(27(31)36)12-18-7-3-4-8-20(18)29/h3-4,6-8,13,19,23-24H,1,5,9-12,14-15H2,2H3/b17-6+/t19-,23-,24-,28+/m0/s1

Standard InChI Key:  AKTGLWBKTXRVGI-NHKBCECNSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 542.54

Molecular Weight (Monoisotopic): 542.1865

AlogP: 2.64

#Rotatable Bonds: 6

Polar Surface Area: 109.13

Molecular Species: NEUTRAL

HBA: 9

HBD: 0

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 0

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa:

CX LogP: 3.59

CX LogD: 3.59

Aromatic Rings: 2

Heavy Atoms: 39

QED Weighted: 0.24

Np Likeness Score: 0.82

References

1. Ding Y, Li S, Ge W, Liu Z, Zhang X, Wang M, Chen T, Chen Y, Zhang Q..  (2019)  Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.,  183  [PMID:31553932] [10.1016/j.ejmech.2019.111706]

Source

Source(1):

• Scientific Literature